|

Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease

RECRUITINGN/ASponsored by Synergic Medical Technologies, Inc.
Actively Recruiting
PhaseN/A
SponsorSynergic Medical Technologies, Inc.
Started2023-03-01
Est. completion2024-12
Eligibility
Age45 Years – 90 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05830110

Summary

The purpose of the present research is to examine the effectiveness of a non-invasive, vibrotactile stimulation protocol, known as coordinated reset (CR), for the alleviation of motor symptoms in patients with Parkinson's disease (PD). PD patients exhibit rigidity, slowness (bradykinesia) and poverty (akinesia) of movement as well as other symptoms. Treatment for PD is either pharmacological (first line) or invasive deep brain stimulation. The non-invasive, vibrotactile stimulation approach uses a novel stimulation pattern to disrupt the pathophysiological mechanism that is responsible for PD symptoms and thus restore motor function.

Eligibility

Age: 45 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* between the ages 45 and 90
* diagnosis of bilateral, moderate stage idiopathic PD
* qualify for EEG procedures

Exclusion Criteria:

* on dopamine agonist medications and exhibiting compulsive behaviors

Conditions1

Parkinson's Disease

Locations1 site

Synergic Medical Technologies
Eugene, Oregon, 97403
Elyria Kabasenche, BS541-510-7068elyria.kabasenche@synergicmed.com

Browse More Trials

Parkinson's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.